Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 101 participants.
Also called NCT03082014
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 101 participants
- Sponsor
- Registry
-
NCT03082014
-
- Other papers using this trial's data
- Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany, Netherlands, United Kingdom
- Registry status
- Terminated
Technical summary
Registry record NCT03082014. Randomized; single masking; primary purpose treatment. Start 2018-02-22 (actual); primary completion 2022-07-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function
- Acronym
- TREAT-SVDs
- Condition
- Cerebral Small Vessel Diseases
- Intervention (Drug)
- Amlodipine
- Intervention (Drug)
- Losartan
- Intervention (Drug)
- Atenolol
- Lead sponsor
- Ludwig-Maximilians - University of Munich
- Collaborator
- University of Edinburgh
- Collaborator
- Maastricht University Medical Center
- Collaborator
- UMC Utrecht
- Collaborator
- University of Oxford
Record details
- Record id
cardio:ct-nct03082014- Content hash
9083df52857d603ad2b879f4b4c65f0495878ebcd38ccad2b48272a5d14bde42